Who We Are
AI Centric Drug Discovery
Palindromic Labs is an AI-centric drug discovery biotechnology company. The company is inspired by the breakthrough Deep Learning AI technology demonstrated by AlphaFold to predict 3D structure of proteins better, cheaper and faster than traditional experimental methods, and is adapting and enhancing this technology to speed up drug discovery.
Palindromic Labs’ Vision
Palindromic Labs’ identity is shaped by the work we do – pushing the boundary of drug discovery with AI-centric technology. Our vision is to make a remarkable impact on people's lives through innovative medicines and healthcare solutions.
Three important forces led to the founding of Palindromic Labs:
Deep Learning
Cloud Computing
2015
High-throughput Screening
Cloud Computing
Cloud Computing technology has enabled shared data and computing resources, allowing new market entrants to compete with large established companies quickly and efficiently.
2015
2016
2017
2017
2018
2019
2020
2021
2021
High-throughput Screening
High-throughput Screening innovation has been made feasible through modern advances in robotics and high-speed computer technology.
Deep Learning
Powered by Deep Learning technology, AlphaFold solved a 50-year-old grand challenge of biology, and became the most important achievement in AI – ever.
2021
2021
Innovation Through Advanced Technology
Palindromic Labs aims to drive drug discovery innovation by integrating Deep Learning technology, Cloud Computing resources, and High-throughput Screening capacity.
We are building a pipeline of promising drug candidates, and will share our development once we reach the clinical phase.
